Jiangsu Hengrui Pharmaceuticals Co., Ltd.
600276 · Shanghai Stock Exchange (SSE) · Pharmaceuticals
About the company
Jiangsu Hengrui Pharmaceuticals is one of China's largest innovative pharmaceutical companies, with a major focus on oncology, anaesthesia, contrast agents, and metabolic disease therapeutics, and an extensive pipeline of novel small molecules and biologics in clinical development. The company has been investing heavily in drug innovation and has received approvals for several products in regulated international markets including the US and Europe. It is a privately controlled company headquartered in Lianyungang, Jiangsu Province.
| Exchange | Shanghai Stock Exchange (SSE) |
| Ticker | 600276 |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $25.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (Shanghai Stock Exchange (SSE)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Shanghai Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in China
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.